Cancer targets and uses thereof
AssigneeCelera Corporation
InventorsDong Fang, Paul Moore, Steve Ruben, Sudeepta Aggarwal
Life of this patent
Estimating the term…
Loading patent…
AssigneeCelera Corporation
InventorsDong Fang, Paul Moore, Steve Ruben, Sudeepta Aggarwal
Estimating the term…
Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (“CAT”). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.
A method of inhibiting proliferation of colon cancer cells in vitro, the method comprising contacting the colon cancer cells in vitro with an isolated antibody that selectively binds to an angiopoietin-like 4 (ANGPTL4) protein to thereby inhibit proliferation of the colon cancer cells in vitro.
Dependencies are inferred from the claim text.